BriaCell Therapeutics Corp.

BCTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.14

-$0.01 (-0.24%)

Sep 22, 2026, 11:02 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $36.1M

Enterprise Value $13.3M

Beta 1.52

Average Volume 283.31K

Shares Outstanding (Diluted) 7.25M

Shares Change YoY 288.19%

Institutional Ownership 5.33%

Exchange NASDAQ

ISIN CA1079303071

Price Performance

Price Change 1M 3.0%

Price Change 3M 38.8%

Price Change 6M 2.5%

Price Change YTD -42.1%

Price Change 1Y -55.9%

Price Change 3Y -99.5%

Price Change 5Y -99.7%

1M CAGR (ann.) 14.0%

1Y CAGR (ann.) -54.3%

5Y CAGR (ann.) -67.6%

All-Time CAGR -45.0%

Valuation

PE Ratio -0.30

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.01

PS Ratio N/A

Forward PS 3.60

PB Ratio 1.54

P/FCF Ratio -1.07

P/Adj. FCF Ratio -1.03

P/OCF Ratio -0.98

EV/Sales N/A

EV/EBIT -0.43

EV/EBITDA -0.43

EV/FCF -0.39

Earnings Yield -333.3%

FCF Yield -93.9%

Adj. FCF Yield -96.7%

Financial Health

Net Cash $22.8M

Total Debt $0

Cash & Short-Term Investments $22.8M

Total Assets $27.07M

Current Ratio 7.07

Quick Ratio 7.07

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage -1,080.17

Altman Z-Score -3.85

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -3.0%

Returns

Return on Assets -113.2%

Return on Equity -147.9%

Return on Invested Capital -136.3%

Return on Capital Employed -136.3%

Return on Tangible Assets -114.0%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 12.2%

EPS CAGR 5Y 18.6%

EPS CAGR 10Y 27.4%

FCF CAGR 3Y 10.7%

FCF CAGR 5Y -19.0%

FCF CAGR 10Y -27.1%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Jun 8, 2026

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-33.9M

Free Cash Flow $-33.9M

Adj. Free Cash Flow $-34.91M

FCF Per Share -$4.27

OCF Per Share -$4.25

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-89.96K

Operating Income $-31.02M

EBITDA $-30.92M

Net Income $-37.06M

EPS (Diluted) -$13.83

Revenue / Employee N/A

Profit / Employee $-2.32M

Employees 16